Details of the Drug

General Information of Drug (ID: DM5ZVLB)

Drug Name
Ixazomib
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Approved [1]
Affected Organisms
Humans and other mammals
ATC Code
L01XG03: Ixazomib
L01XG: Proteasome inhibitors
L01X: OTHER ANTINEOPLASTIC AGENTS
L01: ANTINEOPLASTIC AGENTS
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Structure
3D MOL is unavailable 2D MOL
Chemical Identifiers
Formula
C14H19BCl2N2O4
Canonical SMILES
B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O
InChI
InChI=1S/C14H19BCl2N2O4/c1-8(2)5-12(15(22)23)19-13(20)7-18-14(21)10-6-9(16)3-4-11(10)17/h3-4,6,8,12,22-23H,5,7H2,1-2H3,(H,18,21)(H,19,20)/t12-/m0/s1
InChIKey
MXAYKZJJDUDWDS-LBPRGKRZSA-N
Cross-matching ID
PubChem CID
25183872
ChEBI ID
CHEMBL2141296
CAS Number
1072833-77-2
UNII
71050168A2
DrugBank ID
DB09570
TTD ID
D0Y2SW
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2015